Back to search

Article

Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stress

2024-05-18

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Peripherally restricted cannabinoid CB1 receptor antagonists without central side effects hold promise for treating metabolic disorders including diabetes and obesity. In atherosclerosis, the specific effects of peripheral CB1 signaling in vascular endothelial cells (ECs) remain incompletely understood. <h4>Methods and results</h4> Endothelial expression of the CB1 encoding...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee21f2eb-0299-5430-92a0-f12a379f4a96
DOI
10.1101/2024.05.15.594375
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stressDOI 10.1101/2024.05.15.594375
Select a neighboring publication to make it the new centre.